Key result
Integrating molecular insights with novel lipid-lowering and advanced revascularization promises better atherosclerosis outcomes.
Why the study?
Recent molecular biology advances have deepened understanding of atherosclerosis pathogenesis, opening new avenues to integrate these mechanisms with evolving surgical and interventional strategies.
This review highlights recent advances in understanding atherosclerosis pathophysiology and how these molecular insights are shaping novel pharmacological, imaging, and surgical interventions.
May guide combined molecular-surgical strategies in atherosclerosis; leaves open clinical impact pending prospective trials.
BACKGROUND: Atherosclerosis is a leading cause of cardiovascular disease. Recent advances in molecular biology have deepened our understanding of its pathogenesis and opened new avenues for surgical intervention. METHODS: This review integrates recent findings on key mechanisms-such as endoplasmic reticulum stress, oxidative imbalance, and immune-metabolic dysregulation-with progress in surgical and interventional strategies. RESULTS: Novel targets like UPR pathways, mitochondrial ROS, and microRNAs have shown therapeutic promise. RNA-based lipid-lowering therapies and PCSK9 inhibitors offer alternatives to statins. In parallel, innovations in PCI and CABG-such as next-generation stents, multi-arterial grafting, and engineered vascular conduits-have improved safety and efficacy. Advanced imaging techniques further enhance diagnosis and procedural planning. CONCLUSION: Integrating molecular insights with evolving surgical approaches is transforming atherosclerosis management. A precision strategy combining targeted therapy with individualized revascularization holds promise for better outcomes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) conducted a review in Atherosclerosis. Surgical and pharmacological interventions was evaluated. Integrating molecular insights with evolving surgical approaches, including novel lipid-lowering therapies and advanced revascularization techniques, holds promise for better atherosclerosis outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: